12. FINANCIAL INSTRUMENTS	12 Months Ended
Jun. 30, 2017
Investments, All Other Investments [Abstract]
12. FINANCIAL INSTRUMENTS	The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a multinomial lattice model as of June 30, 2017, and 2016. The fair values of the derivative instruments are measured each quarter, which resulted in a (loss) gain of $(138,693) and $4,376,280, and derivative expense of $376,427 and $0 during the fiscal years ended June 30, 2017 and 2016, respectively. As of June 30, 2017 and 2016, the fair market value of the derivatives aggregated $2,145,065 and $0, respectively, using the following assumptions: estimated 0.12-5.02 year term, estimated volatility of 86.22-125.67%, and a discount rate of 0.44-1.89%.

12. FINANCIAL INSTRUMENTS

12 Months Ended

Jun. 30, 2017

Investments, All Other Investments [Abstract]

The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a multinomial lattice model as of June 30, 2017, and 2016. The fair values of the derivative instruments are measured each quarter, which resulted in a (loss) gain of $(138,693) and $4,376,280, and derivative expense of $376,427 and $0 during the fiscal years ended June 30, 2017 and 2016, respectively. As of June 30, 2017 and 2016, the fair market value of the derivatives aggregated $2,145,065 and $0, respectively, using the following assumptions: estimated 0.12-5.02 year term, estimated volatility of 86.22-125.67%, and a discount rate of 0.44-1.89%.